Dr. Heather Mitchell -- Pharmaceutical Payment Report

This page provides a comprehensive transparency report for Dr. Heather Mitchell, a Neurology physician based in City, MD. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Heather Mitchell has received $14,685.77 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.

Physician Profile

The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.

Payment Summary

Dr. Heather Mitchell has received a total of $14,685.77 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $14,685.77 per transaction.

Payment Breakdown by Category

The following table shows how Dr. Heather Mitchell's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.

Payment CategoryAmountDescription
Speaking & Education$14,685.77Promotional speaking, CME events, and educational presentations

The largest payment category for Dr. Heather Mitchell is Speaking & Education, accounting for 100% ($14,685.77) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.

Pharmaceutical Company Relationships

The following pharmaceutical and medical device companies have made payments to Dr. Heather Mitchell. Click on any company name to view their full physician payment profile and spending patterns.

CompanyTotal PaidTransactions
Allergan (AbbVie)$14,685.771

Dr. Heather Mitchell has a financial relationship with Allergan (AbbVie), receiving $14,685.77 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.

AI Transparency Analysis

The following analysis was generated by artificial intelligence based on Dr. Heather Mitchell's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.

Heather Mitchell has received $14.7K across 1 pharmaceutical payments as a Neurology physician in City, MD. Top paying companies include Allergan (AbbVie) ($14.7K). Dr. Mitchell received a single, substantial payment of $14,686 in 2024. This payment originated entirely from Allergan (AbbVie), representing 100% of her reported pharma payments. The payment was categorized as 'speaking' fees, indicating a potential educational or advisory role.

Patient Guidance: Questions to Ask Your Doctor

If Dr. Heather Mitchell is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:

Patients may wish to ask their neurologist about any financial relationships with pharmaceutical companies, especially if the doctor frequently prescribes medications from a particular manufacturer. Always feel free to ask your doctor directly about their pharmaceutical relationships.

Peer Comparison: How Dr. Heather Mitchell Compares to Other Neurology Physicians

For neurologists, speaking fees from pharmaceutical companies are common, but a single large payment from one company is less typical than more distributed engagements.

Recent Payment Records

The following table shows the most recent pharmaceutical industry payments recorded for Dr. Heather Mitchell in the CMS Open Payments database. Click on any payment to view the full report.

CompanyAmountTypeDrug/DeviceDateConflict Level
Allergan (AbbVie)$14,685.77speakingN/A2024-10-03Not Assessed

Frequently Asked Questions About Dr. Heather Mitchell's Pharma Payments

Below are common questions patients ask about physician pharmaceutical payment data.

How much pharma money has Heather Mitchell received?

Heather Mitchell has received a total of $14.7K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.

Is Heather Mitchell taking too much pharma money?

Heather Mitchell has received $14.7K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Neurology), the types of payments, and how they compare to peers. The largest payment category is speaking ($14.7K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.

What pharma companies pay Heather Mitchell?

The top pharmaceutical companies paying Heather Mitchell are: Allergan (AbbVie) ($14.7K). These payments cover various categories including consulting, meals, speaking fees, and research grants.

What kinds of payments does Heather Mitchell receive?

Heather Mitchell's payments by type: speaking: $14.7K.

Should I switch doctors because of pharma payments?

Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.

How do Heather Mitchell's payments compare to other Neurology doctors?

To compare, look at the total amount ($14.7K), number of payments (1), and the types of payments received. Neurology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.

How can I verify Heather Mitchell's payment data?

You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1356002744). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.

Do pharma payments affect prescribing quality?

Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.

What stands out about Heather Mitchell's pharma payment profile?

The high average payment per transaction suggests a significant engagement, possibly a speaking engagement or consulting role. Heather Mitchell has received $14.7K in total pharma payments.

How does Heather Mitchell compare to peers in Neurology?

For neurologists, speaking fees from pharmaceutical companies are common, but a single large payment from one company is less typical than more distributed engagements.

Are Heather Mitchell's pharma relationships typical for Neurology?

The complete concentration with one company (Allergan/AbbVie) warrants attention for potential influence.

What should patients of Heather Mitchell know about these payments?

Patients may wish to ask their neurologist about any financial relationships with pharmaceutical companies, especially if the doctor frequently prescribes medications from a particular manufacturer.

What patterns are visible in Heather Mitchell's payment history?

The single payment in 2024 makes it difficult to establish a trend or broader pattern of interactions.

Understanding This Doctor Payment Report

This transparency report for Dr. Heather Mitchell is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:

About the Physician Payments Sunshine Act

The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.

Under this law, Dr. Heather Mitchell's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.

The Open Payments data for Dr. Heather Mitchell and all other physicians can be accessed at the official CMS Open Payments website.

Related Resources

Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.